Concepedia

Lu-Meng Zhou

LZ

8

Publications

280

Citations

8

H-Index

2020

Active since

Affiliations

Hubei University of Medicine(Current)

Taihe Hospital

Cell Technology (China)

Xiangyang Central Hospital

Huanggang Central Hospital

Lu-Meng Zhou is an author at Hubei University of Medicine specializing in oncology, molecular diagnostics, and lung cancer.

Top concepts

Publications per year

2020–2022

8

Publications

8

NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu‐Sheng Liu, Lu-Meng Zhou, Lingling Yuan et al. · Frontiers in Immunology · 2021 · 129 citations · Full text

Overexpression of METTL3 associated with the metabolic status on <sup>18</sup>F-FDG PET/CT in patients with Esophageal Carcinoma

Xu‐Sheng Liu, Lingling Yuan, Yan Gao et al. · Journal of Cancer · 2020 · 39 citations · Full text

Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma

Xu‐Sheng Liu, Yan Gao, Libing Wu et al. · Frontiers in Oncology · 2021 · 32 citations · Full text

Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma

Lu-Meng Zhou, Lingling Yuan, Yan Gao et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 21 citations

, , +12

Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma

Xu‐Sheng Liu, Yan Gao, Chao Liu et al. · Frontiers in Oncology · 2021 · 18 citations · Full text

Rows per page

1–5 of 8